| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.55B | +310.6% | +40.0% |
| R&D Expense | $13.6M | -30.1% | — |
| SG&A Expense | $35.3M | +32.0% | -11.5% |
| Operating Income | -$20.3M | -1.0% | +47.3% |
| Pre-tax Income | -$18.7M | +15.2% | +51.5% |
| Income Tax | $367K | +111.5% | — |
| Net Income | -$6.0M | +68.3% | +84.5% |
| EPS (Basic) | -$0.02 | +66.7% | — |
| EPS (Diluted) | -$0.02 | +66.7% | — |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $452.4M | +65.0% | +180.2% |
| Current Assets | $982.8M | +144.6% | +258.7% |
| Total Assets | $4.10B | +241.6% | +280.1% |
| Current Liabilities | $1.16B | +101.1% | +125.8% |
| Total Liabilities | $1.44B | +78.7% | +61.0% |
| Stockholders' Equity | $275.5M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$200.3M | — | -370.3% |
| Capital Expenditures | $520K | — | — |
| Investing Cash Flow | $264.3M | — | — |
| Financing Cash Flow | $394.5M | — | +826.3% |
| Free Cash Flow | -$200.8M | — | -371.5% |
| +52.4% |